Skip to main content
. 2023 Mar 10;44(6):417–426. doi: 10.1097/MNM.0000000000001684

Fig. 1.

Fig. 1

Value of adjunct molecular breast imaging in patients with remaining diagnostic concerns after conventional breast imaging. MBI, molecular breast imaging; CD, conventional diagnostic imaging with mammography and ultrasound. BI-RADS ≤ 3 classifications were considered benign and BI-RADS > 3 classifications were considered malignant. BI-RADS scores were compared with histopathological analysis or at least 6 months follow-up imaging.